Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may help reduce hair loss in androgenic alopecia.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Spironolactone may help reduce hair loss in androgenic alopecia.

Ayurvedic treatments can help manage PCOS symptoms.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Continuing education programs significantly increased rural nurse practitioners' knowledge about PCOS.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Hirsutism treatment should focus more on patient needs and quality of life.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.